Avenira Limited (ASX: AEV) (“Avenira” or “the Company”)”) has secured a Strategic Investment from its largest shareholder, Sichuan Hebang Biotechnology Corporation Limited (SHSE: 603077) (“Hebang”). HIGHLIGHTS: The Strategic Investment comprises:A$4.5 million 2-tranche Placement at an issue price of A$0.006 per new share, with Tranche 2 subject to shareholder approval and…
Zodiac Gold (TSXV:ZAU) is a West African gold exploration company developing a district-scale gold discovery in the Republic of…
Culpeo Minerals Limited (Culpeo or the Company) (ASX:CPO, OTCQB:CPORF) is pleased to announce it has received binding commitments from…
Bold Ventures management believes our suite of Battery, Critical and Precious Metals exploration projects are an ideal combination of…
E-Power Resources Inc. (CSE: EPR) (‘E-Power’ or the ‘Company’) is pleased to report results from the first phase of…
Galan Lithium Limited (ASX: GLN) (Galan or the Company) is pleased to announce that it has utilised its At-the-Market…
Prices for Brent and West Texas crude consolidated through the second quarter of 2024, shedding 2.68 percent and 2.45…
Brightstar Resources Ltd (ASX: BTR) (Brightstar) is pleased to announce it has received firm commitments to raise approximately $24…
High-Tech Metals Limited (ASX: HTM) (High-Tech, HTM or the Company), refers to the announcement dated 6 September 2023 regarding…